RAP 0.00% 20.5¢ resapp health limited

The approach would apply to Pfizer's request for a licence to...

  1. 1,756 Posts.
    lightbulb Created with Sketch. 3054
    The approach would apply to Pfizer's request for a licence to develop the COVID-19 tool.

    In terms of the Scheme the board that wants the sale meets its costs, and it's not Pfizer's.

    Even the RAP board would would say no to a question: "Oh, we want to buy your company. Would you mind meeting the expenses?"
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.